Vimarsana
Biggest News Aggregation in the World

Page 8 - Markl Wolf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markl Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markl Wolf Today - Breaking & Trending Today

Taiwanese Pharma Co. Can't Shake AOP Sanction Bid - Vimarsana News

Taiwanese Pharma Co. Can't Shake AOP Sanction Bid

Taiwanese pharmaceutical company PharmaEssentia can't escape sanctions in Massachusetts federal court for being tight-lipped during discovery in a feud with Austrian pharmaceutical company AOP Orphan over a €142 million arbitral award, a judge ruled Monday.

Source: law360.com
Higham man sentenced for money laundering scheme - Vimarsana News

Higham man sentenced for money laundering scheme

Yannick A. Minang, 27, was sentenced by U.S. District Court Judge Patti B. Sarris to more than four years in prison. Read more at Boston.com.

Source: boston.com
Ex-Aegerion Rep. Not 'Over The Law,' Gets 4 Years For Fraud - Vimarsana News

Ex-Aegerion Rep. Not 'Over The Law,' Gets 4 Years For Fraud

A former Aegerion Pharmaceuticals Inc. salesman convicted of fraud acted "over the law" by boasting that his illegal off-label sales of cholesterol drugs had helped people, a Boston federal judge said Thursday as he handed down a 4½-year sentence.

Source: law360.com
Pharma Co. Wants €140M AOP Orphan Award Suit Tossed - Vimarsana News

Pharma Co. Wants €140M AOP Orphan Award Suit Tossed

Taiwanese pharmaceutical company PharmaEssentia renewed its bid to toss litigation over a disputed €142 million ($165 million) arbitral award secured by Austrian pharmaceutical company AOP Orphan, saying a Massachusetts federal court lacks jurisdiction over the suit because the company has insufficient ties to the state.

Source: law360.com
AOP Orphan Seeks Sanctions On Taiwanese Pharma Co. - Vimarsana News

AOP Orphan Seeks Sanctions On Taiwanese Pharma Co.

Austrian pharmaceutical company AOP Orphan is seeking sanctions against Taiwanese pharmaceutical company PharmaEssentia, saying the latter has so far ducked the former's efforts to establish jurisdiction in litigation to enforce a more than €142 million arbitral award that arose from a soured licensing deal.

Source: law360.com